These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 30155722)

  • 1. In vitro assessment of hepatotoxicity by metabolomics: a review.
    Cuykx M; Rodrigues RM; Laukens K; Vanhaecke T; Covaci A
    Arch Toxicol; 2018 Oct; 92(10):3007-3029. PubMed ID: 30155722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolomics profiling of steatosis progression in HepaRG
    Cuykx M; Claes L; Rodrigues RM; Vanhaecke T; Covaci A
    Toxicol Lett; 2018 Apr; 286():22-30. PubMed ID: 29355688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of extracellular metabolome by HS-SPME/GC-MS: Optimization and application in a pilot study to evaluate galactosamine-induced hepatotoxicity.
    Araújo AM; Moreira N; Lima AR; Bastos ML; Carvalho F; Carvalho M; Guedes de Pinho P
    Toxicol Lett; 2018 Oct; 295():22-31. PubMed ID: 29852275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatoxicity mechanism of cantharidin-induced liver LO2 cells by LC-MS metabolomics combined traditional approaches.
    Liu F; Wang X; Duan C; Zhang J; Li X
    Toxicol Lett; 2020 Oct; 333():49-61. PubMed ID: 32726682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An in vitro metabolomics approach to identify hepatotoxicity biomarkers in human L02 liver cells treated with pekinenal, a natural compound.
    Shi J; Zhou J; Ma H; Guo H; Ni Z; Duan J; Tao W; Qian D
    Anal Bioanal Chem; 2016 Feb; 408(5):1413-24. PubMed ID: 26715247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Systematic Strategy for Screening and Application of Specific Biomarkers in Hepatotoxicity Using Metabolomics Combined With ROC Curves and SVMs.
    Li Y; Wang L; Ju L; Deng H; Zhang Z; Hou Z; Xie J; Wang Y; Zhang Y
    Toxicol Sci; 2016 Apr; 150(2):390-9. PubMed ID: 26781514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Upcyte Hepatocytes: Characterization of the Hepatic Phenotype and Evaluation for Acute and Long-Term Hepatotoxicity Routine Testing.
    Tolosa L; Gómez-Lechón MJ; López S; Guzmán C; Castell JV; Donato MT; Jover R
    Toxicol Sci; 2016 Jul; 152(1):214-29. PubMed ID: 27208088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrative cross-omics analysis in primary mouse hepatocytes unravels mechanisms of cyclosporin A-induced hepatotoxicity.
    Van den Hof WF; Van Summeren A; Lommen A; Coonen ML; Brauers K; van Herwijnen M; Wodzig WK; Kleinjans JC
    Toxicology; 2014 Oct; 324():18-26. PubMed ID: 25047351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human hepatocytes derived from pluripotent stem cells: a promising cell model for drug hepatotoxicity screening.
    Gómez-Lechón MJ; Tolosa L
    Arch Toxicol; 2016 Sep; 90(9):2049-2061. PubMed ID: 27325232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of Drug-Induced Liver Injury in Micropatterned Co-cultures Containing iPSC-Derived Human Hepatocytes.
    Ware BR; Berger DR; Khetani SR
    Toxicol Sci; 2015 Jun; 145(2):252-62. PubMed ID: 25716675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The discovery and development of proteomic safety biomarkers for the detection of drug-induced liver toxicity.
    Amacher DE
    Toxicol Appl Pharmacol; 2010 May; 245(1):134-42. PubMed ID: 20219512
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Huo T; Fang Y; Zhao L; Xiong Z; Zhang Y; Wang Y; Feng C; Yuan M; Wang S; Chen M; Jiang H
    J Ethnopharmacol; 2016 Nov; 192():1-9. PubMed ID: 27377338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of hepatocytes to investigate drug toxicity.
    Gómez-Lechón MJ; Castell JV; Donato MT
    Methods Mol Biol; 2010; 640():389-415. PubMed ID: 20645064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatotoxic constituents and toxicological mechanism of Xanthium strumarium L. fruits.
    Xue LM; Zhang QY; Han P; Jiang YP; Yan RD; Wang Y; Rahman K; Jia M; Han T; Qin LP
    J Ethnopharmacol; 2014 Mar; 152(2):272-82. PubMed ID: 24447814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolomics approaches for discovering biomarkers of drug-induced hepatotoxicity and nephrotoxicity.
    Beger RD; Sun J; Schnackenberg LK
    Toxicol Appl Pharmacol; 2010 Mar; 243(2):154-66. PubMed ID: 19932708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single-injection targeted metabolomics profiling method for determination of biomarkers to reflect tripterygium glycosides efficacy and toxicity.
    Hu T; Shi C; Liu L; Li P; Sun Y; An Z
    Toxicol Appl Pharmacol; 2020 Jan; 389():114880. PubMed ID: 31945383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro evaluation of potential hepatotoxicity induced by drugs.
    Gómez-Lechón MJ; Lahoz A; Gombau L; Castell JV; Donato MT
    Curr Pharm Des; 2010 Jun; 16(17):1963-77. PubMed ID: 20236064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma metabolomics study of the hepatoprotective effect of glycyrrhetinic acid on realgar-induced sub-chronic hepatotoxicity in mice via
    Huo T; Fang Y; Zhang Y; Wang Y; Feng C; Yuan M; Wang S; Chen M; Jiang H
    J Ethnopharmacol; 2017 Aug; 208():36-43. PubMed ID: 28673699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of hepatotoxicity potential with metabolite profiling (metabolomics) of rat plasma.
    Mattes W; Davis K; Fabian E; Greenhaw J; Herold M; Looser R; Mellert W; Groeters S; Marxfeld H; Moeller N; Montoya-Parra G; Prokoudine A; van Ravenzwaay B; Strauss V; Walk T; Kamp H
    Toxicol Lett; 2014 Nov; 230(3):467-78. PubMed ID: 25086301
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.